FDA REPORT ON ENGINEERED TISSUE REGULATORY, SCIENTIFIC ISSUES
This article was originally published in The Gray Sheet
Executive Summary
FDA REPORT ON ENGINEERED TISSUE REGULATORY, SCIENTIFIC ISSUES is under development by a task force of staffers from the agency's centers for devices, drugs, biologics, and veterinary medicine. A draft of the report is expected to be completed by the end of the year. The intercenter working group, which has more than 30 members, was established this summer.